This suggests that it could be involved in inflammatory conditions, including IBD, highlighting the findings of our analysis which revealed HCAR3 to be upregulated in patients with IBD compared to healthy controls (Figure 11). Here, HCAR3 is linked to inflammatory bowel disease.